Journal profile · Oncology
Tumor Biology
ISSN 1010-4283 · eISSN 1423-0380 · SAGE Publications (formerly IOS Press) · SWITZERLAND · Bimonthly · Founded 2010
Tumor Biology: fully open access; APC about USD 2,100; review about 1 month (community reports); community-reported acceptance: about 27.5%; 7 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Tumor Biology is published by SAGE Publications (formerly IOS Press). By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, MicroRNA in disease regulation and Cancer Cells and Metastasis, together about 25.2% of its articles. Its main subfields are Cancer Research and Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Tumor Biology is a peer reviewed, international journal providing an open access forum for experimental and clinical cancer research. It covers all aspects of tumor markers, molecular biomarkers, tumor targeting, and mechanisms of tumor development and progression. This journal is a member of the Committee on Publication Ethics (COPE).
From the journal's Aims & Scope
Research area (LetPub): Oncology
Editor-in-chief Magdalena ChechlinskaPublisher website
Editorial board by country: none in mainland China; most named Netherlands 3, United Kingdom 2, Spain 2, Canada 2, Poland 2 (24 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology9.2%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology8.1%
- Cancer Cells and MetastasisMedicine7.8%
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology6.2%
- Mechanisms of cancer metastasisBiochemistry, Genetics and Molecular Biology5.7%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.4%
- Lung Cancer Research StudiesMedicine4.4%
- Head and Neck Cancer StudiesMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Cancer Research | Q3 | 120/233 | 48th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 5.3LetPub ·
- SJR 2026-06
- 0.8LetPub ·
- SNIP 2026-06
- 0.7LetPub ·
- h-index
- 70LetPub ·
- h-index
- 122OpenAlex ·
- i10-index
- 5,642OpenAlex ·
- 2-year mean citedness
- 3OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 1,625LetPub ·
Articles by year OpenAlex count · 8,679 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 8 | 8 | 5,248 |
| 2025 | 7 | 7 | 9,347 |
| 2024 | 9 | 9 | 11,997 |
| 2023 | 33 | 33 | 13,635 |
| 2022 | 20 | 20 | 16,342 |
| 2021 | 38 | 38 | 19,220 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 27.5%LetPub ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,100 | Yes | CC BY-NC | |
| OpenAlex | USD 2,000 | — | — | |
| LetPub | USD 2,000 | Yes | — | |
| Publisher website | USD 2,100 / USD 1,680 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Keywords
- ≥ 4
- Reference style
- Vancouver
Article types accepted12, with length limits
- article commentaryOpen Access Article commentary First published Aug 16, 2026Length not stated
- case reportPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Original ArticleThis form of manuscript presents new clini…Length not stated
- commentariesCommentariesAre opinion pieces that initiate or focus discussion on current and emerging topics related to tumor biology. This article type should propose a val…Length not stated
- conference reportons, key findings, and recommendations. Conference reports should have a maximum of 2,000 words. Abstracts for this article type are optional. Guideline Armain text ≤ 2,000 words
- editorialPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Original ArticleThis form of manuscript presents new clini…Length not stated
- methods articleto new models or scientific questions. Methods articles should have approximately 4,000 words and a structured abstract with no more than 300 words. Confmain text ≤ 4,000 words
- opinionPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Original ArticleThis form of manuscript presents new clini…Length not stated
- protocolPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Original ArticleThis form of manuscript presents new clini…main text ≤ 4,000 words
- research articleOpen Access Research article First published Jul 1, 2026Length not stated
- reviewPlease visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts. Original ArticleThis form of manuscript presents new clini…main text ≤ 6,000 words
- review articleReview ArticleTumor Biology accepts comprehensive reviews on topics related to experimental and clinical cancer research, and related topics. Reviews must conta…Length not stated
- study protocolsStudy ProtocolsA comprehensive plan of action that contains information concerning the goals of the study, details of subject recruitment, safety monitoring, an…Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Author contributions
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- Open access Publishing fees and open access
Online-only journal Model summary
Tumor Biology is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid by the funder, ins…
Source ↗Publisher website ·- Peer review Peer review policy
Single anonymized review Model summary
The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE Publications (formerly IOS Press)
- Country or region
- SWITZERLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2010
- ISSN
- 1010-4283
- Electronic ISSN
- 1423-0380
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Tumor Biology
How long does peer review take at Tumor Biology?
Authors report an average review time of about 1 month; the community-reported acceptance is “about 27.5%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Tumor Biology?
According to the journal's author guidelines: Keywords: ≥ 4; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Tumor Biology based?
Of the 24 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Netherlands (3), United Kingdom (2) and Spain (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Tumor Biology?
According to LetPub and DOAJ records, Tumor Biology is indexed in Scopus and DOAJ.
Is Tumor Biology open access, and what is the APC?
Tumor Biology is a fully open-access journal. APC about USD 2,100.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .